2020
July 24, 2020
Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research
2019
March 13, 2019
Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers
2018
December 12, 2018
Tvardi Therapeutics names Imran Alibhai Chief Executive Officer
October 01, 2018
Tvardi’s Scientific Advisory Board Member, Dr. Jim Allison, Wins Nobel
September 20, 2018
Tvardi Announces Series A Financing